Apyx Medical Corp - Common Stock (APYX)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
41,059,412
Total 13F shares
18,975,246
Share change
+386,049
Total reported value
$183,295,913
Price per share
$9.66
Number of holders
67
Value change
+$4,233,889
Number of buys
28
Number of sells
28

Institutional Holders of Apyx Medical Corp - Common Stock (APYX) as of Q1 2021

As of 31 Mar 2021, Apyx Medical Corp - Common Stock (APYX) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,975,246 shares. The largest 10 holders included RTW INVESTMENTS, LP, Archon Capital Management LLC, BlackRock Inc., VANGUARD GROUP INC, PURA VIDA INVESTMENTS, LLC, JPMORGAN CHASE & CO, HORIZON KINETICS ASSET MANAGEMENT LLC, Taylor Frigon Capital Management LLC, ROYCE & ASSOCIATES LP, and COWEN AND COMPANY, LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.